김재호 교수
학력
한국과학기술원(KAIST) 바이오및뇌공학과 졸업 부산대학교 의학전문대학원 의무석사 성균관대학교 의과대학 의학과 박사 (신경과학 전공) |
경력
삼성서울병원 신경과 전공의 삼성서울병원 신경과 임상강사 서울시 강남구 치매 안심센터 부센터장 Harvard Medical School, Brigham and Women’s Hospital, Research fellow 한림대학교동탄성심병원 신경과 임상조교수 한림대학교동탄성심병원 신경과 조교수 |
학회활동
대한치료초음파학회 연구이사 대한인지중재치료학회 정보이사 대한치매학회 학술간사 AAIC Advancements/IC-KDA 2027 Scientific Program Committee Member 대한두통학회 정회원 대한신경과학회 정회원 North American Neuromodulation Society American Association of Neurology The International Parkinson and Movement Disorder Society International Headache Society |
수상이력
The 2020 HAI Travel Scholarship, Human Amyloid Imaging, Miami, FL, USA 뉴로프런티어 펠로우쉽 연구비상, 대한신경과학회 2021 대한치매학회 학술연구지원상 2023 대한인지중재치료학회 추계학술대회 우수구연상 2024 대한치매학회 춘계학술대회 우수구연상 2025 대한인지중재치료학회 학술연구지원상 |
논문/저서
|
국제학회지 발표논문 1. Feasibility and safety of repeated low-intensity ultrasound in amyloid PET-positive early Alzheimer's disease: A prospective pilot study, Journal of Alzheimer’s Disease (2026) 2. Short-Term Cognitive and Behavioral Changes After Low-Intensity Transcranial Ultrasound Stimulation in Early Alzheimer’s Disease: An IPTW-Adjusted Retrospective Exploratory Comparative Study, Brain Sciences (2026) 3. Effects of Low-Intensity Ultrasound on Amyloid-β Clearance in Early-Stage Alzheimer′s Disease: A Potential Role of Glymphatic Activity, Acta Neurologica Scandinavica (2026) 4. Brain Glymphatic and Lymphatic Systems in Migraine: Mechanistic Insights and Neuromodulation Perspectives with an Emphasis on Ultrasound-Based Approaches, Headache and Pain Research (2026) 5. Plasma Phosphorylated Tau 217 Cutoffs for Amyloid Pathology and Kidney Function, Body Mass Index, and Anemia, JAMA neurology (2026) 6. Clearance of amyloid plaque via focused ultrasonication in a mouse model of Alzheimer’s disease, Theranostics (2026) 7. Prognostic Value of A/T/N Biomarkers Comparing Plasma and Imaging Modalities in Alzheimer Disease, Clinical Nuclear Medicine (2025) 8. Executive Summary of 2025 International Conference of the Korean Dementia Association and International Congress of the Asian Society Against Dementia (IC-KDA/ASAD 2025): A Report From the Academic Committee of the Korean Dementia Association, Dementia and Neurocognitive Disorders (2025) 9. Establishing Regional Aβ Cutoffs and Exploring Subgroup Prevalence Across Cognitive Stages Using BeauBrain Amylo, Dementia and Neurocognitive Disorders (2025) 10. Temporal Dynamics and Biological Variability of Alzheimer Biomarkers, JAMA neurology (2025) 11. Differential roles of Alzheimer’s disease plasma biomarkers in stepwise biomarker-guided diagnostics, Alzheimer's & Dementia (2025) 12. Effects of Cognitive and Depressive Status on Empathy in Healthy Elderly, Amnestic MCI, and Dementia of the Alzheimer’s Type, Dementia and Neurocognitive Disorders (2025) 13. Spatial discrimination in patients with MSA, PSP, DIP, and VP with pain, Scientific reports (2024) 14. Low-frequency EEG power and coherence differ between drug-induced parkinsonism and Parkinson’s disease, Clinical Neurophysiology (2024) 15. Transcranial Focused Ultrasound Stimulation Enhances Cerebrospinal Fluid Movement: Real-Time In Vivo Two-Photon and Widefield Imaging Evidence, Brain Stimulation (2024) 16. Executive Summary of 2023 International Conference of the Korean Dementia Association (IC-KDA 2023): A Report From the Academic Committee of the Korean Dementia Association, Dementia and Neurocognitive Disorders (2024) 17. Association between migraine and the risk of vascular dementia: A nationwide longitudinal study in South Korea, PLoS One (2024) 18. The association between migraine and Parkinson’s disease: a nationwide cohort study, Epidemiol Health (2024) 19. Scaling problem in Parkinson’s disease patients with pain, Parkinsonism and Related Disorders (2023) 20. Association between migraine and alzheimer’s disease: A Nationwide Cohort study, Frontiers in Aging Neuroscience (2023) 21. Identifying genetic variants for amyloid β in subcortical vascular cognitive impairment, Frontiers in Aging Neuroscience (2023) 22. Clinical outcomes of increased focal amyloid uptake in individuals with subthreshold global amyloid levels, Frontiers in Aging Neuroscience (2023) 23. Agreement and Reliability between Clinically Available Software Programs in Measuring Volumes and Normative Percentiles of Segmented Brain Regions, KJR (2022) 24. Enhancement of cerebrospinal fluid tracer movement by the application of pulsed transcranial focused ultrasound, Scientific reports (2022) 25. Ethnic differences in the frequency of β-amyloid deposition in cognitively normal individuals, Neurobiology of Aging (2022) 26. Transcutaneous Application of Ultrasound Enhances the Effects of Finasteride in Murine Model of Androgenic Alopecia, Ultrasonography (2022) 27. Differential effects of risk factors on cognitive trajectories in early-onset and late-onset Alzheimer’s disease, Alzheimer's Research & Therapy (2021) 28. Identification of novel genetic variants for brain amyloid deposition: a genome-wide association study in Korean population, Alzheimer's Research & Therapy (2021) 29. Prediction of brain tau accumulation in amyloid positive cognitive impairment patients using multimodal biomarkers with machine learning approach, Scientific reports (2021) 30. Predicting amyloid positivity in patients with mild cognitive impairment using a radiomics approach, Scientific reports (2021) 31. Strictly lobar microbleeds reflect amyloid angiopathy regardless of cerebral and cerebellar compartments, Stroke (2020) 32. Clinical utility of Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer’s Disease in Korea, JKMS (2020) 33. Optical coherence tomography angiography as a potential screening tool for cerebral small vessel diseases, Alzheimer's Research & Therapy (2020) 34. Posterior Reversible Encephalopathy Syndrome as Initial Manifestation of Autoimmune Encephalitis, Neurology: Clinical Practice (2019) 35. The Cortical Neuroanatomy Related to Specific Neuropsychological Deficits in Alzheimer's Continuum, Dementia and Neurocognitive Disorders (2019) 36. Atypical clinical presentations in patients with right hemispheric infarcts: Complex stories beyond neurological examinations and diffusion-weighted MRI, Precision and Future Medicine (2018) 37. Brain embolic infarction associated with cardiac amyloidosis in a Patient with Multiple Myeloma: A Bone marrow-Heart-Brain Crosstalk, Precision and Future Medicine (2018) 38. The impact of APOE e4 in Alzheimer’s disease differs according to age. Journal of Alzheimer’s disease (2018) |